Takeshi Osonoi Selected Research

1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitol

1/2019

Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Osonoi Research Topics

Disease

41	Type 2 Diabetes Mellitus (MODY) 01/2024 - 04/2010
16	Atherosclerosis 12/2023 - 02/2011
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2011
9	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 12/2010
8	Hyperglycemia 04/2022 - 01/2014
7	Carotid Artery Diseases 01/2023 - 04/2010
5	Body Weight (Weight, Body) 01/2024 - 03/2016
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 07/2010
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2013
4	Albuminuria 01/2021 - 02/2016
2	Chronic Renal Insufficiency 01/2022 - 11/2020
2	Diabetes Mellitus 09/2021 - 12/2016
2	Hyperkalemia 02/2021 - 12/2020
2	Weight Gain 12/2017 - 03/2014
1	Peripheral Arterial Disease 01/2023
1	Anemia 01/2023
1	Hyperuricemia 01/2022
1	Chronic Disease (Chronic Diseases) 02/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Dementia (Dementias) 10/2019
1	Myocardial Infarction 10/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Inflammation (Inflammations) 10/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2018
1	Insulin Resistance 03/2018
1	Obesity 12/2016
1	Arteriosclerosis 03/2015

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 12/2010
9	Insulin (Novolin)FDA Link 01/2022 - 12/2010
8	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 01/2013
7	GlucosidasesIBA 03/2021 - 12/2010
7	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 03/2014
6	Hypoglycemic Agents (Hypoglycemics)IBA 04/2022 - 03/2016
5	alogliptinIBA 01/2023 - 01/2013
5	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2023 - 10/2017
5	miglitol (Glyset)FDA Link 03/2021 - 12/2010
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 10/2017
4	Acarbose FDA LinkGeneric 04/2022 - 12/2010
4	Metformin (Glucophage)FDA LinkGeneric 04/2022 - 12/2016
3	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2019
3	SodiumIBA 09/2021 - 10/2010
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 09/2018
3	Liraglutide FDA Link 11/2020 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 07/2014
3	LipidsIBA 03/2018 - 02/2011
2	sodium zirconium cyclosilicateIBA 02/2021 - 12/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2010
2	HDL CholesterolIBA 01/2021 - 02/2011
2	CholesterolIBA 01/2021 - 12/2010
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2020 - 06/2014
2	CanagliflozinIBA 12/2019 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 03/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2015 - 07/2010
2	Monocyte Chemoattractant ProteinsIBA 09/2014 - 07/2010
2	voglibose (Basen)IBA 09/2014 - 12/2010
2	Pioglitazone (Actos)FDA Link 10/2010 - 04/2010
1	tirzepatideIBA 01/2024
1	dulaglutideIBA 01/2024
1	finerenoneIBA 01/2023
1	imegliminIBA 01/2023
1	dapagliflozinIBA 01/2023
1	IronIBA 01/2023
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2022
1	dotinuradIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Febuxostat FDA Link 01/2022
1	IndicanIBA 01/2022
1	Messenger RNA (mRNA)IBA 03/2021
1	CationsIBA 02/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	PotassiumIBA 12/2020
1	CreatinineIBA 11/2020
1	Glucagon (Glukagon)FDA Link 12/2019
1	Peptides (Polypeptides)IBA 12/2019
1	trelagliptinIBA 11/2019
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2019
1	Collagen Type IV (Type IV Collagen)IBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	8-Hydroxy-2'-DeoxyguanosineIBA 10/2018
1	AlbuminsIBA 10/2018
1	semaglutideIBA 01/2018
1	VildagliptinIBA 12/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	LeptinIBA 12/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2016
1	anagliptinIBA 12/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2016
1	Oxidants (Oxidizing Agents)IBA 03/2015
1	HydrogenIBA 03/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2014

Therapy/Procedure

14	Therapeutics 04/2022 - 03/2014
12	Glycemic Control 01/2023 - 01/2013
2	Aftercare (After-Treatment) 01/2024 - 11/2020
1	Drug Therapy (Chemotherapy) 03/2021